Natco Pharma Limited NATCOPHARM

Latest filings

• Fund raising79 28 Sept, 20:52 · BSE
  Outcome of Fund Raising Committee Meeting approving the Letter of Offer for Rights Issue
• General50 28 Sept, 14:58 · BSE
  Press Release and disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
• Routine15 26 Sept, 16:12 · BSE
  Newspaper Publication of Record date for Rights Issue
• Fund raising60 25 Sept, 11:23 · NSE
  Record date for the purpose of Rights is 01-Oct-2026.
• Fund raising75 25 Sept, 11:21 · NSE
  Issue of Securities on Rights Basis
• Fund raising65 25 Sept, 11:17 · NSE
  Board of Directors at its meeting held on September 25, 2026, has decided to issue equity shares on rights basis in the ratio of 2 : 21, i.e 2 Equity Shares for every 21 Equity Shares held at an Issue Price of Rs. 750 per share (including a premium of ₹ 748/- (Rupees Seven Hundred and Forty Eight only) per Rights Equity Share)
• Board meeting40 22 Sept, 17:56 · BSE
  Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2026 ,inter alia, to consider and approve to consider, discuss and decide ....
• Fund raising73 21 Sept, 22:48 · NSE
  'Intimation regarding receipt of In-Principle Approval for the Rights Issue '.
• Fund raising73 9 Sept, 17:48 · NSE
  Intimation of Draft letter of Offer
• Board meeting50 9 Sept, 11:53 · NSE
  Outcome of Board Meeting held on September 09, 2026.

Shown 15 minutes after publication. Real time with Pro.